DCIS-Mi also appears to have a more aggressive biological phenotype with a greater tendency toward larger lesion size, axillary LN metastases, higher grade, comedo necrosis, ER-negativity, PR-negativity, and HER2-positivity. This evidence concerns the gene PGR and ductal breast carcinoma in situ.